RhumbLine Advisers’s Atara Biotherapeutics ATRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $2.51K | Hold |
|
|||||
|
2025
Q2 | $1.35K | Hold |
|
|||||
|
2025
Q1 | $1.04K | Hold |
|
|||||
|
2024
Q4 | $2.33K | Hold |
|
|||||
|
2024
Q3 | $1.42K | Sell |
|
|||||
|
2024
Q2 | $5.8K | Sell |
|
|||||
|
2024
Q1 | $102K | Buy |
|
|||||
|
2023
Q4 | $74.6K | Sell |
|
|||||
|
2023
Q3 | $215K | Buy |
|
|||||
|
2023
Q2 | $230K | Sell |
|
|||||
|
2023
Q1 | $427K | Buy |
|
|||||
|
2022
Q4 | $469K | Buy |
|
|||||
|
2022
Q3 | $536K | Buy |
|
|||||
|
2022
Q2 | $1.08M | Buy |
|
|||||
|
2022
Q1 | $1.11M | Sell |
|
|||||
|
2021
Q4 | $2.02M | Buy |
|
|||||
|
2021
Q3 | $2.26M | Sell |
|
|||||
|
2021
Q2 | $1.98M | Buy |
|
|||||
|
2021
Q1 | $1.67M | Sell |
|
|||||
|
2020
Q4 | $2.41M | Buy |
|
|||||
|
2020
Q3 | $1.39M | Buy |
|
|||||
|
2020
Q2 | $1.55M | Buy |
|
|||||
|
2020
Q1 | $628K | Buy |
|
|||||
|
2019
Q4 | $1.15M | Buy |
|
|||||
|
2019
Q3 | $961K | Buy |
|
|||||
|
2019
Q2 | $1.24M | Buy |
|
|||||
|
2019
Q1 | $2.19M | Sell |
|
|||||
|
2018
Q4 | $1.96M | Buy |
|
|||||
|
2018
Q3 | $1.54M | Sell |
|
|||||
|
2018
Q2 | $1.44M | Buy |
|
|||||
|
2018
Q1 | $1.31M | Buy |
|
|||||
|
2017
Q4 | $492K | Sell |
|
|||||
|
2017
Q3 | $523K | Buy |
|
|||||
|
2017
Q2 | $439K | Buy |
|
|||||
|
2017
Q1 | $579K | Buy |
|
|||||
|
2016
Q4 | $388K | Sell |
|
|||||
|
2016
Q3 | $592K | Buy |
|
|||||
|
2016
Q2 | $600K | Buy |
|
|||||
|
2016
Q1 | $329K | Sell |
|
|||||
|
2015
Q4 | $459K | Buy |
|
|||||
|
2015
Q3 | $441K | Buy |
|
|||||
|
2015
Q2 | $654K | Buy |
|